Health at a Glance: Europe 2020

State of Health in the EU Cycle

image of Health at a Glance: Europe 2020

The 2020 edition of Health at a Glance: Europe focuses on the impact of the COVID‑19 crisis. Chapter 1 provides an initial assessment of the resilience of European health systems to the COVID-19 pandemic and their ability to contain and respond to the worst pandemic in the past century. Chapter 2 reviews the huge health and welfare burden of air pollution as another major public health issue in European countries, and highlights the need for sustained efforts to reduce air pollution to mitigate its impact on health and mortality. The five other chapters provide an overview of key indicators of health and health systems across the 27 EU member states, 5 EU candidate countries, 3 European Free Trade Association countries and the United Kingdom. Health at a Glance: Europe is the first step in the State of Health in the EU cycle.


Incidence, survival and mortality for lung cancer

In Europe, lung cancer is the second most commonly diagnosed form of cancer after prostate cancer among men, and the third most common cancer after breast and colorectal cancer among women. In 2020, about 320 000 people in EU countries are expected to be newly diagnosed with lung cancer, and it is expected to continue to be the leading cause of cancer death with over 257 000 deaths across the EU (JRC, 2020). The main risk factors for lung cancer are tobacco smoking and environmental factors, particularly air pollution.



This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error